Denmark· DK-28105725716
Refixia
A coagulation factor ix product containing nonacog betapegol, registered in Denmark by Novo Nordisk A/S. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Coagulation factor ix is registered in 12 of 19 countries.
Countries holding a registration under ATC B02BD04 (coagulation factor ix), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Coagulation factor ix · ATC B02BD04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Nonacog betapegol
- Manufacturer
- Novo Nordisk A/S
- Country
- Denmark (DK)
- ATC code
- B02BD04
- ATC class
- Coagulation factor IX
- Defined daily dose
- 600 E, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105725716
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for coagulation factor ix.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor ix · interactions on record
3 records
- 2 severe
- 1 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- PegvaliaseA16AB19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02BD04
Coagulation factor ix, as other registers publish it.
- SwitzerlandAlprolix
- PolandAlprolixSwedish Orphan Biovitrum AB
- PolandAlprolixSwedish Orphan Biovitrum AB
- PolandAlprolixSwedish Orphan Biovitrum AB
- PolandAlprolixSwedish Orphan Biovitrum AB
- DenmarkAlprolixSwedish Orphan Biovitrum AB
- PolandAlprolixSwedish Orphan Biovitrum AB
- IcelandAlprolix*Swedish Orphan Biovitrum AB (publ)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/adfa6a86-d250-4eb5-a9d9-e886dccd4227 GET /v1/drugs/adfa6a86-d250-4eb5-a9d9-e886dccd4227?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver og solvens til injektionsvæske, opløsning",
"source": "dkma",
"strength": "500 IE",
"auth_role": "MOD",
"dk_drugid": "28105725716",
"substance": "Nonacog betapegol",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42888"
}See everything about coagulation factor ix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.